Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Propanc Biopharma Inc (PPCB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 6,065
  • Shares Outstanding, K 202,180
  • Annual Sales, $ 0 K
  • Annual Income, $ -7,040 K
  • 36-Month Beta 7.08
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.26
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/22/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0260 +26.92%
on 11/15/18
0.0779 -57.64%
on 10/18/18
-0.0385 (-53.85%)
since 10/16/18
3-Month
0.0039 +746.15%
on 08/27/18
0.2888 -88.57%
on 09/05/18
+0.0262 (+385.29%)
since 08/16/18
52-Week
0.0039 +746.15%
on 08/27/18
0.7700 -95.71%
on 12/08/17
-0.0570 (-63.33%)
since 11/16/17

Most Recent Stories

More News
Propanc Biopharma Initiates European Validation of its Lead Patent

Propanc Biopharma, Inc. (OTCQB: PPCB) ("Propanc Biopharma" or the "Company"), a clinical stage biopharmaceutical company focusing on development of new and proprietary treatments for cancer patients suffering...

PPCHD : 1.2000 (+20.00%)
PPCB : 0.0326 (+8.67%)
Propanc Biopharma Enters into Research Collaboration Agreement with the University of Jaén

Propanc Biopharma, Inc. (OTCQB: PPCB) ("Propanc Biopharma" or the "Company"), a clinical stage biopharmaceutical company focusing on development of new and proprietary treatments for cancer patients suffering...

PPCHD : 1.2000 (+20.00%)
PPCB : 0.0326 (+8.67%)
Propanc Biopharma Provides Shareholder Update after Presenting at the 25th Annual NewsMakers in the Biotech Industry Conference

Propanc Biopharma, Inc. (OTCQB: PPCB) ("Propanc Biopharma" or the "Company"), a clinical stage biopharmaceutical company focusing on development of new and proprietary treatments for cancer patients suffering...

PPCHD : 1.2000 (+20.00%)
PPCB : 0.0326 (+8.67%)
Propanc Biopharma Selected to Present at the 25th Annual NewsMakers in the Biotech Industry

Propanc Biopharma Inc. (OTCQB: PPCB) ("Propanc Biopharma" or the "Company"), a clinical stage biopharmaceutical company focusing on development of new and proprietary treatments for cancer patients suffering...

PPCHD : 1.2000 (+20.00%)
PPCB : 0.0326 (+8.67%)
Propanc Biopharma Selected to Present at the 25th Annual NewsMakers in the Biotech Industry

MELBOURNE, Australia , Aug. 9, 2018 /PRNewswire/ --  Propanc Biopharma Inc. (OTCQB: PPCB) ("Propanc Biopharma" or the "Company"), a clinical stage biopharmaceutical company focusing on development...

PPCB : 0.0326 (+8.67%)
New Report Released on Growing Biotech Sector

FN Media Group Presents Microcapspeculators.com News Commentary

DRNA : 13.49 (-0.66%)
PPCHD : 1.2000 (+20.00%)
IONS : 52.68 (+1.95%)
PPCB : 0.0326 (+8.67%)
CASI : 3.76 (+6.82%)
INSM : 16.60 (-1.43%)
Companies that Stand to Benefit from the Biotech Market Bottoming

FN Media Group Presents Microcapspeculators.com News Commentary

SRNE : 3.62 (+0.56%)
CELG : 69.51 (-0.67%)
CBAY : 9.43 (-0.42%)
ECYT : 23.65 (+0.17%)
PPCB : 0.0326 (+8.67%)
Propanc Biopharma Completes Scientific Advice Meeting with MHRA

MELBOURNE, Australia , April 10, 2018 /PRNewswire/ --  Propanc Biopharma Inc. (OTCQB: PPCB) ("Propanc Biopharma" or the "Company"), a clinical stage biopharmaceutical company focusing on development...

PPCB : 0.0326 (+8.67%)
Propanc Biopharma Completes Scientific Advice Meeting with MHRA

Propanc Biopharma Inc. (OTCQB: PPCB) ("Propanc Biopharma" or the "Company"), a clinical stage biopharmaceutical company focusing on development of new and proprietary treatments for cancer patients suffering...

PPCHD : 1.2000 (+20.00%)
PPCB : 0.0326 (+8.67%)
Biotech Market Poised to Reach 2015 Highs

FN Media Group Presents Microcapspeculators.com News Commentary

PPCHD : 1.2000 (+20.00%)
INNT : 2.92 (-1.35%)
PPCB : 0.0326 (+8.67%)
ONCS : 0.82 (+2.50%)
GERN : 1.52 (-3.18%)
LPTX : 3.73 (+6.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators mostly agree with the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade PPCB with:

Key Turning Points

2nd Resistance Point 0.0337
1st Resistance Point 0.0319
Last Price 0.0326
1st Support Level 0.0271
2nd Support Level 0.0241

See More

52-Week High 0.7700
Fibonacci 61.8% 0.4773
Fibonacci 50% 0.3869
Fibonacci 38.2% 0.2966
Last Price 0.0326
52-Week Low 0.0039

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar